Buy Afinitor 7.5 mg/1 everolimus

Afinitor 7.5 mg tablets contain everolimus, a medication used to manage certain conditions. Learn about its uses, effects, and precautions for safe handling.

Strength

7.5 mg/1

Pack Size

28 BLISTER PACK in 1 CARTON (0078-0620-51) / 1 TABLET in 1 BLISTER PACK (0078-0620-61)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Afinitor 7.5 mg tablets are primarily used to treat specific medical conditions as part of a broader treatment plan. Everolimus, the active ingredient, is often prescribed for its potential to support the management of certain health issues. Patients may wonder, 'What is Afinitor used for?' and it is generally utilized in scenarios where targeted therapy is beneficial.

Side Effects

Common effects of Afinitor 7.5 mg tablets may include mild to moderate reactions that vary among individuals. Some users might experience changes in appetite, fatigue, or skin conditions. It's important to monitor any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Handling Afinitor 7.5 mg tablets requires attention to storage and administration guidelines. Keep the medication in a cool, dry place away from direct sunlight. Always follow the prescribed dosage and avoid sharing the medication with others unless directed by a healthcare professional.

Avoid Interactions

Afinitor 7.5 mg tablets may interact with certain substances, including alcohol and other medications. It's advisable to inform your healthcare provider about all current medications to avoid potential interactions. Some drugs, particularly those metabolized by the liver, may affect the efficacy of everolimus.

References

Frequently Asked Questions

Afinitor 7.5 mg tablets are used to manage specific medical conditions as part of a comprehensive treatment plan.

Store Afinitor 7.5 mg tablets in a cool, dry place away from direct sunlight and out of reach of children.

Common effects may include changes in appetite, fatigue, or skin conditions. Always consult a healthcare provider for personalized advice.

Afinitor may interact with other medications. Inform your healthcare provider about all current medications to avoid potential interactions.

Afinitor is available in various strengths. Consult your healthcare provider to determine the appropriate strength for your needs.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.